Delivery Order SPE2DR25D1047-SPE2DR26F24F8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,309.37 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This firm fixed price, competitively awarded contract was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/mL pen injectors, with a ceiling value of $6,822.36. This firm fixed-price delivery order, awarded on August 19, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen will perform this supply delivery from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors valued at $3,013.20, with a firm fixed price and ultimate completion date of December 12, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,004.40 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors under a firm fixed price contract. This non-set-aside delivery order, issued on December 30, 2025, with an ultimate completion date of December 31, 2025, will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,674.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors, with an ultimate completion date of December 11, 2025. This is a non-set-aside, competitively awarded contract with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $2,334.15 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this requirement as a competitive award under its existing contract vehicle with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,990.63 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the...
- The Defense Logistics Agency awarded a $1,378.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of August 14, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfillment through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product is a migraine treatment medication that will be delivered to the contracting location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Emgality 120 mg/ml pen injectors, valued at $2,840.86 under firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 15, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and...
- The Defense Logistics Agency awarded a $1,859.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on November 7, 2025, with completion targeted for November 10, 2025. This non-competitive, competitively awarded delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The pharmaceutical...
- SPE2DR25D1047Indefinite Delivery Contract
- SPE2DR25D1047-SPE2DR26F24F8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,725.65 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/mL pen injectors. This contract, awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, represents a competitively awarded, non-set-aside order under a firm fixed price arrangement. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its prime IDC with the Defense Logistics Agency to fulfill federal medical procurement requirements across multiple therapeutic domains. The company's contract portfolio with DLA demonstrates its capability to supply an extensive range of pharmaceutical products, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government entities worldwide. This delivery order for Emgality—a migraine treatment medication—exemplifies the routine pharmaceutical supply operations conducted through AmerisourceBergen's established federal contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/4/26 |